Medical Papers

Purpose: To introduce Nimodipine, a calcium channel blocker, as a potential treatment for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (ME/CFS), highlighting its benefits, mechanisms, and usage protocols. Key Points: Potential Benefits: Improves mental clarity, alertness, energy levels, and stamina. Reduces fatigue, muscle pain, and headaches for some patients. Approximately half of users report noticeable improvement with minimal…

Purpose: To provide an in-depth exploration of the potential benefits, mechanisms, and practical considerations of using Nimodipine, a calcium channel blocker, for managing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Key Points: Drug Overview: Nimodipine is a second-generation L-type calcium channel blocker, primarily used to improve blood flow in the brain by relaxing blood vessel walls. It…

Purpose: To shed light on the profound challenges faced by individuals with Severe/Very Severe Myalgic Encephalomyelitis (ME), emphasizing the physical nature of the illness and the need for accurate understanding and support. Key Points: Misinterpretation of Symptoms: Severe ME symptoms are often dismissed or misinterpreted as psychological due to their invisibility and complexity. Terms like…

Purpose: To explore the historical misrepresentation of Myalgic Encephalomyelitis (ME) as merely “fatigue,” highlighting the scientific evidence that supports its classification as a chronic neurological disease. Key Points: Origins of Misrepresentation: ME was historically dismissed as “fatigue syndrome,” overshadowing the broader neurological symptoms such as muscle pain, cognitive issues, and impaired circulation. Lack of understanding…

Purpose: To highlight the groundbreaking research on B-cell depletion therapy for severely affected Myalgic Encephalomyelitis (ME) patients, emphasizing the potential benefits, clinical findings, and future research directions. Key Points: Accidental Discovery: Norwegian oncologists, Dr. Øystein Fluge and Professor Olav Mella, observed “major symptom relief” in a cancer patient with severe ME undergoing chemotherapy. This led…

Purpose: To establish that Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a physical disorder, countering efforts to classify it as a psychiatric or behavioral condition. Key Points: WHO and Official Recognition: The WHO confirmed in 2014 that ME/CFS is not classified as a mental or behavioral disorder in ICD-10 or proposed for ICD-11. The UK government…

Purpose: To discuss the clinical features, potential causes, and management strategies for Myalgic Encephalomyelitis (ME), emphasizing the importance of early rest and understanding of the condition. Key Points: Clinical Features: ME often follows a viral infection and presents with persistent fatigue, muscle weakness, headaches, blurred vision, and neurological symptoms such as difficulty concentrating and memory…

Purpose: To examine the long-term impacts of Myalgic Encephalomyelitis (ME), its parallels with Post-Polio Syndrome, and the need for improved recognition, research, and management strategies. Key Points: Nature of ME: ME is a chronic neurological illness caused by enteroviral infections, leading to multi-system impacts, including skeletal, cardiac, and endocrine organ damage. Symptoms include overwhelming fatigue,…